Browse Drug Recalls
17,582 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 17,582 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 17,582 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Sep 21, 2023 | fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only,... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total V... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc.... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syring... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 6... | Failed Dissolution Specifications | Class II | Zydus Pharmaceuticals (USA) Inc |
| Sep 21, 2023 | midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Cen... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx ... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, ... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 21, 2023 | fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAP... | Lack of assurance of sterility: | Class II | Central Admixture Pharmacy Services Inc |
| Sep 20, 2023 | MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile O... | Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0%... | Class III | Imprimis NJOF, LLC |
| Sep 20, 2023 | Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech In... | Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP... | Class I | KVK-Tech, Inc. |
| Sep 12, 2023 | Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, S... | Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product. | Class III | Tolmar, Inc. |
| Sep 8, 2023 | TheraBreath for Kids! Oral Rinse, sodium fluoride 0.05% (0.02% w/v fluoride i... | Microbial contamination of Non-Sterile Product; presence of yeast identified as Candida parapsilosis | Class I | Church & Dwight Inc |
| Sep 8, 2023 | SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL b... | Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals. | Class I | Novartis Pharmaceuticals Corp. |
| Sep 7, 2023 | Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouche... | Subpotent: Out of Specification result observed for low assay | Class III | SUN PHARMACEUTICAL INDUSTRIES INC |
| Sep 5, 2023 | Kroger Mint Burst ANTISEPTIC MOUTH RINSE ANTIGINGIVITIS/ANTIPLAQUE (Eucalypto... | Incorrect/Undeclared Excipients. | Class III | Vi-Jon, LLC |
| Sep 5, 2023 | Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-... | Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials. | Class II | BE PHARMACEUTICALS AG |
| Sep 1, 2023 | TRP Natural Eyes, Stye Relief, Sterile Eye Ointment, Homeopathic 0.14 oz (4 g... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Pink Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ ... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Blur Relief, Sterile Eye Drops, Homeopathic 0.5 FL OZ (15 m... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Pink Eye Relief PF, Sterile Eye drops, Homeopathic 0.33 FL ... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Dryness Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL O... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Twitching Relief, Sterile Eye Ointment, Homeopathic 0.33 FL... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Dryness Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Eye Lid Relief, Sterile Eye ointment, Homeopathic 0.14 oz (... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Floaters Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ ... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Red Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | MAJOR LubriFresh P.M. Nighttime Ointment, Lubricant Eye Ointment, Sterile, 0.... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Aging Eye Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Eye Lid Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL O... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Allergy Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL O... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per cart... | Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged prod... | Class III | Amerisource Health Services LLC |
| Sep 1, 2023 | octiq Lubricating Eye Drops, Dextran 70.01%, Hypromellose 0.3%, 0.5 FL OZ Eac... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Red Eye Relief PF, Sterile Eye drops, Homeopathic 0.33 FL O... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Sep 1, 2023 | TRP Natural Eyes, Allergy Eyes Relief, Sterile Eye Drops, Homeopathic 0.33 FL... | Lack of Assurance of Sterility | Class II | AMMAN PHARMACEUTICAL INDUSTRIES |
| Aug 30, 2023 | Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL ... | Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results | Class II | VistaPharm LLC |
| Aug 29, 2023 | Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 9... | Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packag... | Class III | RB Health (US) LLC |
| Aug 26, 2023 | Dr. Berne's MSM DROPS 15% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr... | CGMP Deviations | Class II | Dr. Berne's Whole Health Products |
| Aug 26, 2023 | Dr. Berne's MSM DROPS 5% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr.... | CGMP Deviations | Class II | Dr. Berne's Whole Health Products |
| Aug 26, 2023 | Dr. Berne's Organic Castor Oil Eye Drops, Net WT 30 mL/1 fl oz bottle, Distri... | CGMP Deviations | Class II | Dr. Berne's Whole Health Products |
| Aug 26, 2023 | Dr. Berne's MSM MIST 15% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr.... | CGMP Deviations | Class II | Dr. Berne's Whole Health Products |
| Aug 26, 2023 | Dr. Berne's MSM DROPS 5% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr.... | Non-Sterility | Class I | Dr. Berne's Whole Health Products |
| Aug 25, 2023 | BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isoprop... | Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep" Clear 1... | Class II | CareFusion 213, LLC |
| Aug 25, 2023 | Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/D... | Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets,... | Class I | Marlex Pharmaceuticals, Inc. |
| Aug 25, 2023 | WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Br... | Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenaf... | Class I | Hua Da Trading, Inc. dba Wefun Inc. |
| Aug 25, 2023 | Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Di... | Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets,... | Class II | Marlex Pharmaceuticals, Inc. |
| Aug 24, 2023 | Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL)... | CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions dur... | Class II | Baxter Healthcare Corporation |
| Aug 23, 2023 | Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufa... | Defective Container: slow leakage under the cap | Class III | Contract Pharmaceuticals Limited Canada |
| Aug 22, 2023 | Florbetaben F-18 (Neuraceq¿) Injection Solution 1.4 to 135 mCi/mL, 50 mL in 1... | Lack of Assurance of Sterility: out-of-specification test results observed for Filter Integrity T... | Class II | Sofie Co dba Sofie |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.